SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: SJS who wrote (7360)4/9/1999 6:11:00 PM
From: Barron Von Hymen  Read Replies (1) | Respond to of 9523
 
Nice job Dave: Pfizer Inc. Reiterated 'Strong Buy' at Gruntal


Princeton, New Jersey, April 9 (Bloomberg Data) -- Pfizer Inc. (PFE US) was reiterated ''strong
buy'' by analyst David F. Saks at Gruntal & Co. The 12-month target price is $177.00 per share.
NYSE/AMEX delayed 20 min. NASDAQ delayed 15 min.



To: SJS who wrote (7360)4/10/1999 1:06:00 AM
From: synchro  Read Replies (1) | Respond to of 9523
 
I thought it's sometime in June.